Patents by Inventor Heting LI

Heting LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12093241
    Abstract: A method for replaying a log on a data node, a data node, and a database system are described. The method is used to improve a log replay speed, and includes: the data node obtaining a plurality of logs, wherein the plurality of logs includes at least one transaction commit log and at least one page operation log; and a first thread of a plurality of threads replaying the at least one page operation log, and a same second thread replaying all page operation logs including an operation on a same page. As such, log replay progress does not need to be synchronized between threads. A process in which the first thread replays the transaction commit log is independent of a process in which at least one second thread replays the at least one page operation log.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: September 17, 2024
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Qiong Zhang, Xuli Li, Heting Li, Geyong Yao, Xiang Hu
  • Publication number: 20230137119
    Abstract: A method for replaying a log on a data node, a data node, and a database system are described. The method is used to improve a log replay speed, and includes: the data node obtaining a plurality of logs, wherein the plurality of logs includes at least one transaction commit log and at least one page operation log; and a first thread of a plurality of threads replaying the at least one page operation log, and a same second thread replaying all page operation logs including an operation on a same page. As such, log replay progress does not need to be synchronized between threads. A process in which the first thread replays the transaction commit log is independent of a process in which at least one second thread replays the at least one page operation log.
    Type: Application
    Filed: December 28, 2022
    Publication date: May 4, 2023
    Inventors: Qiong ZHANG, Xuli LI, Heting LI, Geyong YAO, Xiang HU
  • Publication number: 20210171536
    Abstract: The present application relates to a crystalline form of 4-(4-chloroanilino)-7-(2-methylaminocarbonyl-4-oxymethyl)pyridylfuro[2,3-d]pyridazine mesylate (EOC315) that contains crystalline form Mod. I. The present application also relates to a process for the preparation of the crystalline form and the pharmaceutical use of the crystalline form.
    Type: Application
    Filed: February 19, 2021
    Publication date: June 10, 2021
    Applicant: Taizhou EOC Pharma Co., Ltd.
    Inventors: Heting LI, Deqiang WANG, Wei CHANG, Hongrui YU, Xiaoming ZOU
  • Patent number: 10954246
    Abstract: A crystalline form of Mod. I of Formula I: And, a process for the preparation of the crystalline form and a pharmaceutical use of the crystalline form.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: March 23, 2021
    Assignee: Taizhou EOC Pharma Co., Ltd.
    Inventors: Heting Li, Deqiang Wang, Wei Chang, Hongrui Yu, Xiaoming Zou
  • Publication number: 20200071336
    Abstract: The present application relates to a crystalline form of 4-(4-chloroanilino)-7-(2-methylaminocarbonyl-4-oxymethyl)pyridylfuro[2,3-d]pyridazine mesylate (EOC315) that contains crystalline form Mod. I. The present application also relates to a process for the preparation of the crystalline form and the pharmaceutical use of the crystalline form.
    Type: Application
    Filed: October 11, 2019
    Publication date: March 5, 2020
    Applicant: Taizhou EOC Pharma Co., Ltd.
    Inventors: Heting LI, Deqiang WANG, Wei CHANG, Hongrui YU, Xiaoming ZOU